BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Modica MN, Lacivita E, Intagliata S, Salerno L, Romeo G, Pittalà V, Leopoldo M. Structure-Activity Relationships and Therapeutic Potentials of 5-HT7 Receptor Ligands: An Update. J Med Chem 2018;61:8475-503. [PMID: 29767995 DOI: 10.1021/acs.jmedchem.7b01898] [Cited by in Crossref: 22] [Cited by in F6Publishing: 21] [Article Influence: 5.5] [Reference Citation Analysis]
Number Citing Articles
1 Jin J, Zhang K, Dou F, Hao C, Zhang Y, Cao X, Gao L, Xiong J, Liu X, Liu B, Zhang G, Chen Y. Isoquinolinone derivatives as potent CNS multi-receptor D2/5-HT1A/5-HT2A/5-HT6/5-HT7 agents: Synthesis and pharmacological evaluation. European Journal of Medicinal Chemistry 2020;207:112709. [DOI: 10.1016/j.ejmech.2020.112709] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
2 Ofori E, Onyameh EK, Gonela UM, Voshavar C, Bricker B, Swanson TL, Eshleman AJ, Schmachtenberg JL, Bloom SH, Janowsky AJ, Ablordeppey SY. New dual 5-HT1A and 5-HT7 receptor ligands derived from SYA16263. Eur J Med Chem 2021;214:113243. [PMID: 33582388 DOI: 10.1016/j.ejmech.2021.113243] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
3 Penna E, Niso M, Podlewska S, Volpicelli F, Crispino M, Perrone-Capano C, Bojarski AJ, Lacivita E, Leopoldo M. In Vitro and In Silico Analysis of the Residence Time of Serotonin 5-HT7 Receptor Ligands with Arylpiperazine Structure: A Structure-Kinetics Relationship Study. ACS Chem Neurosci 2022;13:497-509. [PMID: 35099177 DOI: 10.1021/acschemneuro.1c00710] [Reference Citation Analysis]
4 Turnaturi R, Chiechio S, Salerno L, Rescifina A, Pittalà V, Cantarella G, Tomarchio E, Parenti C, Pasquinucci L. Progress in the development of more effective and safer analgesics for pain management. Eur J Med Chem 2019;183:111701. [PMID: 31550662 DOI: 10.1016/j.ejmech.2019.111701] [Cited by in Crossref: 20] [Cited by in F6Publishing: 16] [Article Influence: 6.7] [Reference Citation Analysis]
5 Lee J, Kwag R, Lee S, Kim D, Woo J, Cho Y, Kim HJ, Kim J, Jeon B, Choo H. Discovery of G Protein-Biased Ligands against 5-HT7R. J Med Chem 2021;64:7453-67. [PMID: 34032427 DOI: 10.1021/acs.jmedchem.1c00110] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
6 Tempio A, Niso M, Laera L, Trisolini L, Favia M, Ciranna L, Marzulli D, Petrosillo G, Pierri CL, Lacivita E, Leopoldo M. Mitochondrial Membranes of Human SH-SY5Y Neuroblastoma Cells Express Serotonin 5-HT7 Receptor. Int J Mol Sci 2020;21:E9629. [PMID: 33348850 DOI: 10.3390/ijms21249629] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
7 Lacivita E, Niso M, Stama ML, Arzuaga A, Altamura C, Costa L, Desaphy JF, Ragozzino ME, Ciranna L, Leopoldo M. Privileged scaffold-based design to identify a novel drug-like 5-HT7 receptor-preferring agonist to target Fragile X syndrome. Eur J Med Chem 2020;199:112395. [PMID: 32442850 DOI: 10.1016/j.ejmech.2020.112395] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
8 El Khamlichi C, Reverchon F, Hervouet-Coste N, Robin E, Chopin N, Deau E, Madouri F, Guimpied C, Colas C, Menuet A, Inoue A, Bojarski AJ, Guillaumet G, Suzenet F, Reiter E, Morisset-Lopez S. Serodolin, a β-arrestin-biased ligand of 5-HT7 receptor, attenuates pain-related behaviors. Proc Natl Acad Sci U S A 2022;119:e2118847119. [PMID: 35594393 DOI: 10.1073/pnas.2118847119] [Reference Citation Analysis]
9 Perry CK, Casey AB, Felsing DE, Vemula R, Zaka M, Herrington NB, Cui M, Kellogg GE, Canal CE, Booth RG. Synthesis of novel 5-substituted-2-aminotetralin analogs: 5-HT1A and 5-HT7 G protein-coupled receptor affinity, 3D-QSAR and molecular modeling. Bioorganic & Medicinal Chemistry 2020;28:115262. [DOI: 10.1016/j.bmc.2019.115262] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
10 Kim D, Lee J, Kwag R, Kim H, Oh H, Moon B, Kim HJ, Seong J, Jeon B, Kang T, Choo H. N ‐(Biphenyl‐3‐ylmethyl)ethanamines as G protein‐biased agonists of 5‐HT 7 R . Bulletin Korean Chem Soc. [DOI: 10.1002/bkcs.12427] [Reference Citation Analysis]
11 Khan H, Pervaiz A, Intagliata S, Das N, Nagulapalli Venkata KC, Atanasov AG, Najda A, Nabavi SM, Wang D, Pittalà V, Bishayee A. The analgesic potential of glycosides derived from medicinal plants. Daru 2020;28:387-401. [PMID: 32060737 DOI: 10.1007/s40199-019-00319-7] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
12 Penna E, Pizzella A, Cimmino F, Trinchese G, Cavaliere G, Catapano A, Allocca I, Chun JT, Campanozzi A, Messina G, Precenzano F, Lanzara V, Messina A, Monda V, Monda M, Perrone-Capano C, Mollica MP, Crispino M. Neurodevelopmental Disorders: Effect of High-Fat Diet on Synaptic Plasticity and Mitochondrial Functions. Brain Sci 2020;10:E805. [PMID: 33142719 DOI: 10.3390/brainsci10110805] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
13 Romeo G, Salerno L, Pittalà V, Candido M, Intagliata S, Amata E, Salmona M, Cagnotto A, Rescifina A, Floresta G, Modica MN. [1]Benzothieno[3,2-d]pyrimidine derivatives as ligands for the serotonergic 5-HT7 receptor. European Journal of Medicinal Chemistry 2019;183:111690. [DOI: 10.1016/j.ejmech.2019.111690] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
14 Liu T, Song J, Zhou Q, Chu S, Liu Y, Zhao X, Ma Z, Xia T, Gu X. The role of 5-HT7R in the memory impairment of mice induced by long-term isoflurane anesthesia. Neurobiol Learn Mem 2022;:107584. [PMID: 35032676 DOI: 10.1016/j.nlm.2022.107584] [Reference Citation Analysis]
15 Kułaga D, Jaśkowska J, Satała G, Latacz G, Śliwa P. Aminotriazines with indole motif as novel, 5-HT7 receptor ligands with atypical binding mode. Bioorganic Chemistry 2020;104:104254. [DOI: 10.1016/j.bioorg.2020.104254] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
16 Partyka A, Zagórska A, Kotańska M, Walczak M, Jastrzębska-Więsek M, Knutelska J, Bednarski M, Głuch-Lutwin M, Mordyl B, Janiszewska P, Wesołowska A. Antidepressant-like activity and safety profile evaluation of 1H-imidazo[2,1-f]purine-2,4(3H,8H)-dione derivatives as 5-HT1A receptor partial agonists. PLoS One 2020;15:e0237196. [PMID: 32764777 DOI: 10.1371/journal.pone.0237196] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
17 Carbone C, Lo Russo SLM, Lacivita E, Frank A, Alleva E, Stark H, Saso L, Leopoldo M, Adriani W. Prior Activation of 5-HT7 Receptors Modulates the Conditioned Place Preference With Methylphenidate. Front Behav Neurosci 2019;13:208. [PMID: 31619973 DOI: 10.3389/fnbeh.2019.00208] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
18 Hogendorf AS, Hogendorf A, Popiołek-Barczyk K, Ciechanowska A, Mika J, Satała G, Walczak M, Latacz G, Handzlik J, Kieć-Kononowicz K, Ponimaskin E, Schade S, Zeug A, Bijata M, Kubicki M, Kurczab R, Lenda T, Staroń J, Bugno R, Duszyńska B, Pilarski B, Bojarski AJ. Fluorinated indole-imidazole conjugates: Selective orally bioavailable 5-HT7 receptor low-basicity agonists, potential neuropathic painkillers. Eur J Med Chem 2019;170:261-75. [PMID: 30904783 DOI: 10.1016/j.ejmech.2019.03.017] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 3.3] [Reference Citation Analysis]
19 Kwag R, Lee J, Kim D, Lee H, Yeom M, Woo J, Cho Y, Kim HJ, Kim J, Keum G, Jeon B, Choo H. Discovery of G Protein-Biased Antagonists against 5-HT7R. J Med Chem 2021;64:13766-79. [PMID: 34519505 DOI: 10.1021/acs.jmedchem.1c01093] [Reference Citation Analysis]
20 Kucwaj-Brysz K, Baltrukevich H, Czarnota K, Handzlik J. Chemical update on the potential for serotonin 5-HT6 and 5-HT7 receptor agents in the treatment of Alzheimer's disease. Bioorg Med Chem Lett 2021;49:128275. [PMID: 34311086 DOI: 10.1016/j.bmcl.2021.128275] [Reference Citation Analysis]
21 Kułaga D, Drabczyk AK, Satała G, Latacz G, Rózga K, Plażuk D, Jaśkowska J. Design and synthesis of new potent 5-HT7 receptor ligands as a candidate for the treatment of central nervous system diseases. Eur J Med Chem 2022;227:113931. [PMID: 34710746 DOI: 10.1016/j.ejmech.2021.113931] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
22 Intagliata S, Sharma A, King TI, Mesangeau C, Seminerio M, Chin FT, Wilson LL, Matsumoto RR, McLaughlin JP, Avery BA, McCurdy CR. Discovery of a Highly Selective Sigma-2 Receptor Ligand, 1-(4-(6,7-Dimethoxy-3,4-dihydroisoquinolin-2(1H)-yl)butyl)-3-methyl-1H-benzo[d]imidazol-2(3H)-one (CM398), with Drug-Like Properties and Antinociceptive Effects In Vivo. AAPS J 2020;22:94. [PMID: 32691179 DOI: 10.1208/s12248-020-00472-x] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 4.0] [Reference Citation Analysis]
23 Liu B, Chu S, Liu T, Song J, Ma Z, Gu X, Xia T. Effects of 5-HT7 receptors on circadian rhythm of mice anesthetized with isoflurane. Chronobiol Int 2021;38:38-45. [PMID: 33081564 DOI: 10.1080/07420528.2020.1832111] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
24 Canale V, Kotańska M, Dziubina A, Stefaniak M, Siwek A, Starowicz G, Marciniec K, Kasza P, Satała G, Duszyńska B, Bantreil X, Lamaty F, Bednarski M, Sapa J, Zajdel P. Design, Sustainable Synthesis and Biological Evaluation of a Novel Dual α2A/5-HT7 Receptor Antagonist with Antidepressant-Like Properties. Molecules 2021;26:3828. [PMID: 34201675 DOI: 10.3390/molecules26133828] [Reference Citation Analysis]
25 Bucki A, Marcinkowska M, Śniecikowska J, Zagórska A, Jamrozik M, Pawłowski M, Głuch-Lutwin M, Siwek A, Jakubczyk M, Pytka K, Jastrzębska-Więsek M, Partyka A, Wesołowska A, Mierzejewski P, Kołaczkowski M. Multifunctional 6-fluoro-3-[3-(pyrrolidin-1-yl)propyl]-1,2-benzoxazoles targeting behavioral and psychological symptoms of dementia (BPSD). Eur J Med Chem 2020;191:112149. [PMID: 32105980 DOI: 10.1016/j.ejmech.2020.112149] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
26 L'Estrade ET, Erlandsson M, Edgar FG, Ohlsson T, Knudsen GM, Herth MM. Towards selective CNS PET imaging of the 5-HT7 receptor system: Past, present and future. Neuropharmacology 2020;172:107830. [PMID: 31669129 DOI: 10.1016/j.neuropharm.2019.107830] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 2.3] [Reference Citation Analysis]
27 Porter MR, Xiao H, Wang J, Smith SB, Topczewski JJ. 3-Amino-chromanes and Tetrahydroquinolines as Selective 5-HT2B, 5-HT7, or σ1 Receptor Ligands. ACS Med Chem Lett 2019;10:1436-42. [PMID: 31620230 DOI: 10.1021/acsmedchemlett.9b00225] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.7] [Reference Citation Analysis]